Skip to main content

Advertisement

SpringerLink
Log in

Depression and epilepsy: Do glucocorticoids and glutamate explain their relationship?

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Depression is the most common psychiatric comorbidity in people with epilepsy, but it remains underrecognized and undertreated. In addition to its negative impact on quality of life, depressive disorders are predictive of a worse response to pharmacologic and surgical treatment of seizure disorders. This phenomenon is probably an expression of a bidirectional relationship between epilepsy and depression, which in turn is indicative of common pathogenic mechanisms that are operant in the two conditions. The abnormal role of the hypothalamic-pituitary-adrenal axis is one of the common pathogenic mechanisms that explains why patients with depression are at greater risk for developing epilepsy and vice versa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Kanner AM, Balabanov A: Depression in epilepsy: how closely related are these two disorders? Neurology 2002, 58(Suppl 5):S27–S39.

    PubMed  Google Scholar 

  2. Tellez-Zenteno JF, Patten SB, Jetté N, et al.: Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.

    Google Scholar 

  3. Wiegartz P, Seidenberg M, Woodard A, et al.: Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999, 53(Suppl 2):S3–S8.

    PubMed  CAS  Google Scholar 

  4. Kanner AM, Kozak AM, Frey M: The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000, 1:100–105.

    Article  PubMed  Google Scholar 

  5. Ettinger AB, Weisbrot DM, Nolan EE, et al.: Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998, 39:595–599.

    Article  PubMed  CAS  Google Scholar 

  6. de Marinis A, Bustamante F, Asmad C, et al.: Prevalence and underrecognition of depression in patients with epilepsy: the experience of the chilean league against epilepsy [abstract]. Epilepsia 2006. Presented at the annual meeting of the American Epilepsy Society. San Diego; December 2–5, 2006.

  7. Mendez MF, Cummings J, Benson D, et al.: Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986, 43:766–770.

    PubMed  CAS  Google Scholar 

  8. Gilliam F: Optimizing health outcomes in active epilepsy. Neurology 2002, 58(Suppl 5):S9–S19.

    PubMed  Google Scholar 

  9. Lehrner J, Kalchmayr R, Serles W, et al.: Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999, 8:88–92.

    Article  PubMed  CAS  Google Scholar 

  10. Perrine K, Hermann BP, Meador KJ, et al.: The relationship of neuropsychological functioning to quality of life in epilepsy [see comments]. Arch Neurol 1995, 52:997–1003.

    PubMed  CAS  Google Scholar 

  11. Gilliam F, Kuzniecky R, Faught E, et al.: Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997, 38:233–236.

    Article  PubMed  CAS  Google Scholar 

  12. Cramer JA, Blum D, Reed M, Fanning K: The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003, 4:515–521.

    Article  PubMed  Google Scholar 

  13. Cramer JA, Blum D, Fanning K, Reed M: The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004, 5:337–342.

    Article  PubMed  Google Scholar 

  14. Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta-analysis. Arch Neurol 1989, 46:1065–1068.

    Google Scholar 

  15. Jones JE, Hermann BP, Barry JJ, et al.: Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4:S31–S38.

    Article  PubMed  Google Scholar 

  16. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics: Statistical Review and Evaluation: Antiepileptic Drugs and Suicidality. Available at http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4372b1-01-FDA.pdf. Accessed May 21, 2009.

  17. Hesdorffer DC, Kanner AM: The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia (in press).

  18. Hitiris N, Mohanraj R, Norrie J, et al.: Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75:192–196.

    Article  PubMed  CAS  Google Scholar 

  19. Kanner AM, Byrne R, Chicharro A, et al.: A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 2009, 72:793–799.

    Article  PubMed  CAS  Google Scholar 

  20. Anhoury S, Brown RJ, Krishnamoorthy ES, Trimble MR: Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia 2000, 41:1608–1615.

    Article  PubMed  CAS  Google Scholar 

  21. Forsgren L, Nystrom L: An incident case referent study of epileptic seizures in adults. Epilepsy Res 1999, 6:66–81.

    Article  Google Scholar 

  22. Hesdorffer DC, Hauser WA, Annegers JF, et al.: Major depression is a risk factor for seizures in older adults. Ann Neurol 2000, 47:246–249.

    Article  PubMed  CAS  Google Scholar 

  23. Hesdorffer DC, Hauser WA, Olafsson E, et al.: Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol 2006, 59:35–41.

    Article  PubMed  Google Scholar 

  24. Kanner AM: Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci 2008, 10:39–45.

    PubMed  Google Scholar 

  25. Kanner AM: Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr 2005, 5:21–27.

    Article  PubMed  Google Scholar 

  26. Kanner AM: Do epilepsy and depression share common pathogenic mechanisms? A look at depression in epilepsy. Clin Neurosc Res 2004, 4:31–37.

    Article  Google Scholar 

  27. Charney DS, Berman RM, Miller HL: Treatment of depression. In Textbook of Psychopharmacology, edn 2. Edited by Schatzberg AF, Nemeroff CB. Washington, DC: American Psychiatric Association Press; 1998:705–732.

    Google Scholar 

  28. Mazarati AM, Shin D, Kwon YS, et al.: Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis 2009, 34:457–461.

    Article  PubMed  CAS  Google Scholar 

  29. Zobel A, Wellmer J, Schulze-Rauschenbach S, et al.: Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy. Eur Arch Psychiatry Clin Neurosci 2004, 254:303-311.

    Google Scholar 

  30. Holsboer F: Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 2001, 62:77–91.

    Article  PubMed  CAS  Google Scholar 

  31. Sheline YI: Brain structural changes associated with depression. In Depression and Brain Dysfunction. Edited by Gilliam F, Kanner AM, Sheline YI. London: Taylor & Francis; 2005:85–104.

    Google Scholar 

  32. Sheline YI, Gado MH, Kraemer HC: Untreated depression and hippocampal volume loss. Am J Psychiatry 2003, 160:1516–1518.

    Article  PubMed  Google Scholar 

  33. Lucassen PJ, Muller MB, Holsboer F, et al.: Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 2001, 158:453–468.

    PubMed  CAS  Google Scholar 

  34. Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000, 57:925–935.

    Article  PubMed  CAS  Google Scholar 

  35. Sapolsky RM, Uno H, Rebert CS, Finch CE: Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990, 10:2897–2902.

    PubMed  CAS  Google Scholar 

  36. Smith MA, Makino S, Kvetnansky R, Post RM: Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci 1995, 771:234–239.

    Article  PubMed  CAS  Google Scholar 

  37. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995, 15:7539–7547.

    PubMed  CAS  Google Scholar 

  38. Chen B, Dowlatshahi D, MacQueen GM, et al.: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001, 50:260–265.

    Article  PubMed  CAS  Google Scholar 

  39. Scimemi A, Schorge S, Kullmann DM, Walker MC: Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path. J Neurophysiol 2006, 95:1213–1220.

    Article  PubMed  CAS  Google Scholar 

  40. Del Rio J, Frechilla D: Glutamate and depression. In Dopamine and Glutamate in Psychiatric Disorders. Edited by Schmidt WE, Reith MAE. Totowa, NJ: Humana Press; 2005:215–233.

    Google Scholar 

  41. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, et al.: Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 2001, 132:1423–1430.

    Article  PubMed  CAS  Google Scholar 

  42. Tatarczynska E, Palucha A, Szewczyk B, et al.: Anxiolyticand antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Pol J Pharmacol 2002, 54:707–710.

    PubMed  CAS  Google Scholar 

  43. Berman RM, Cappiello A, Anand A, et al.: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47:351–354.

    Article  PubMed  CAS  Google Scholar 

  44. Baram TZ, Mitchell WG, Brunson K, Haden E: Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists. Dev Neurosci 1999, 21:281–289.

    Article  PubMed  CAS  Google Scholar 

  45. Wang W, Dow KE, Fraser DD: Elevated corticotropin releasing hormone/corticotropin releasing hormone-R1 expression in postmortem brain obtained from children with generalized epilepsy. Ann Neurol 2001, 50:404–409.

    Article  PubMed  CAS  Google Scholar 

  46. Gilliam FG, Barry JJ, Hermann BP, et al.: Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006, 5:399–405

    Article  PubMed  Google Scholar 

  47. Kroenke K, Spitzer RL, Williams JB, et al.: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317–325.

    PubMed  Google Scholar 

  48. Sheehan BV, Lecrubier Y, Sheehan KH, et al.: The Mini International Neuropsychiatric Interview (MINI): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22–33.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL, 60612, USA

    Andres M. Kanner

Authors
  1. Andres M. Kanner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andres M. Kanner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanner, A.M. Depression and epilepsy: Do glucocorticoids and glutamate explain their relationship?. Curr Neurol Neurosci Rep 9, 307–312 (2009). https://doi.org/10.1007/s11910-009-0046-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-009-0046-1

Keywords

Search

Navigation